SFCM
TRAW icon

Seven Fleet Capital Management’s Traws Pharma TRAW Stock Holding History

Seven Fleet Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,260
Closed -$55.7K – 142
2025
Q4 		$55.7K Buy
+49,260
New +$110K 0.04% 77

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Seven Fleet Capital Management's TRAW Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Traws Pharma (TRAW) in Q1 2026, closing a stake of 49,260 shares — an estimated $55.7K sold.

Seven Fleet Capital Management first reported a position in TRAW in Q4 2025 and held it in 1 quarter. The position peaked at $55.7K in Q4 2025. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Seven Fleet Capital Management reported no remaining Traws Pharma position as of Q1 2026 after selling out during the quarter.
  • Seven Fleet Capital Management sold 49,260 Traws Pharma shares in Q1 2026, an estimated $55.7K.
  • Seven Fleet Capital Management first reported a position in Traws Pharma in Q4 2025 and held it in 1 quarter.
  • Seven Fleet Capital Management's Traws Pharma position peaked at $55.7K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.